SCHEMBL22301048

SCHEMBL22301048

COc1cc(-c2nc(C)c(-c3cccs3)[nH]2)cc(OC)c1O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD3 Q9NY59 16/20 0.78
KDM4E B2RXH2 5/20 0.73
ALDH1A1 P00352 5/20 0.73
MAPT P10636 5/20 0.73
HPGD P15428 5/20 0.73
MEN1 O00255 3/20 0.73
KMT2A Q03164 3/20 0.73
GAA P10253 2/20 0.73
LMNA P02545 3/20 0.59
PPARG P37231 2/20 0.59
NCOA2 Q15596 2/20 0.59
NCOA1 Q15788 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
HTT P42858 2/20 0.59
POLB P06746 1/20 0.59
NPSR1 Q6W5P4 2/20 0.58
MAPK1 P28482 1/20 0.58
HSD17B10 Q99714 1/20 0.58
NCOA3 Q9Y6Q9 1/20 0.58
TDP1 Q9NUW8 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL22291126 0.99 SMPD3 (0.77) SMPD3KDM4EALDH1A1MAPTHPGD
SCHEMBL12106316 0.88 SMPD3 (1.00) SMPD3KDM4EALDH1A1MAPTHPGD
SCHEMBL22291134 0.85 SMPD3 (1.00) SMPD3KDM4EALDH1A1MAPTHPGD
SCHEMBL21315904 0.82 SMPD3 (0.85) SMPD3KDM4EALDH1A1MAPTHPGD
SCHEMBL29580411 0.82 ALDH1A1 (0.58) SMPD3KDM4EALDH1A1MAPTHPGD
SCHEMBL22291217 0.81 SMPD3 (0.76) SMPD3KDM4EALDH1A1MAPTHPGD
SCHEMBL12103578 0.79 SMPD3 (0.82) SMPD3KDM4EALDH1A1MAPTHPGD
SCHEMBL22291125 0.74 SMPD3 (1.00) SMPD3NOX1
SCHEMBL6467333 0.74 MAPT (1.00) SMPD3KDM4EALDH1A1MAPTHPGD
SCHEMBL22301592 0.73 SMPD3 (1.00) SMPD3KDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119374-A1 SMALL MOLECULE NEUTRAL SPHINGOMYELINASE 2 (nSMase2) INHIBITORS THE JOHNS HOPKINS UNIVERSITY 2022-04-21 US disclosed
WO-2020160148-A1 SMALL MOLECULE NEUTRAL SPHINGOMYELINASE 2 (NSMASE2) INHIBITORS THE JOHNS HOPKINS UNIVERSITY (US) 2020-08-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119374-A1 SMALL MOLECULE NEUTRAL SPHINGOMYELINASE 2 (nSMase2) INHIBITORS SMPD2, SPTLC2, SGMS2 SMPD3 8/4885KDM4E 1559/4885ALDH1A1 3995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.